About
Sakura Bio is an innovative biotech company transforming cell therapy for cancer with effective, durable, and accessible T and NK cell treatments. Their core technology, T-Boost, enhances the potency, persistence, and resistance of reprogrammed T and NK cells against the tumor microenvironment. They aim to develop next-generation T/NK cell therapies with superior potency and durability to drive long-lasting clinical responses.
Technology stack
detected 2026-06-18Est. monthly stack spend~$110/mo
Email
Microsoft 365
Stack
Wix
Observability
Sentry
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Sakura Bio do?
Sakura Bio is an innovative biotech company transforming cell therapy for cancer with effective, durable, and accessible T and NK cell treatments. Their core technology, T-Boost, enhances the potency, persistence, and resistance of reprogrammed T and NK cells against the tumor microenvironment. They aim to develop next-generation T/NK cell therapies with superior potency and durability to drive long-lasting clinical responses.
Where is Sakura Bio headquartered?
Sakura Bio is headquartered in Cambridge, United States.
When was Sakura Bio founded?
Sakura Bio was founded in 2017.
What industry does Sakura Bio operate in?
Sakura Bio operates in Life Sciences, Biopharmaceutical, Therapeutics, Biotech, Drug Discovery, Genomics.
How many employees does Sakura Bio have?
Sakura Bio has approximately 4 people on record.